Ingalls & Snyder LLC Gilead Sciences, Inc. Call Options Transaction History

Ingalls & Snyder LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2021 Aug 03, 2021	BUY	$63.47 - $69.35 $285,615 - $312,075	4,500 Added 80.36%	10,100 $695,000
Q1 2021 Apr 21, 2021	BUY	$60.0 - $68.46 $246,000 - $280,686	4,100 Added 273.33%	5,600 $362,000
Q4 2020 Jan 27, 2021	SELL	$56.65 - $64.55 $458,865 - $522,855	-8,100 Reduced 84.38%	1,500 $87,000
Q4 2017 Jan 19, 2018	BUY	$71.15 - $83.52 $683,040 - $801,792	9,600	9,600 $688,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

Stay updated on Ingalls & Snyder LLC with notifications on news.